Publication | Open Access
Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring BRAF, MET, or HER2 Alterations
10
Citations
28
References
2023
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1